Update: Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge — United States, December 2019

Details

• Journal Article:
  Morbidity and Mortality Weekly Report
• Personal Author:
  Evans, Mary E. ; Twentyman, Evelyn ; Click, Eleanor S. ; Goodman, Alyson B. ; Weissman, David N. ; Kiernan, Emily A. ; Adkins, Susan H. ; Mikosz, Christina A. ; Danielson, Melissa ; Anderson, Kayla N. ; Ellington, Sascha ; Lozier, Matthew J. ; Pollack, Lori A. ; Rose, Dale A. ; Krishnasamy, Vikram P. ; Jones, Christopher M. ; Briss, Peter A. ; King, Brian A. ; Wiltz, Jennifer L.
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) Lung Injury Clinical Task Force ; Lung Injury Response Clinical Working Group
• Description:
  What is already known on this topic? In a recent examination of rehospitalization and death among previously hospitalized patients with e-cigarette or vaping, product use-associated lung injury (EVALI), at least one quarter of rehospitalizations and deaths occurred within 2 days of discharge; comorbidities were common among patients who were rehospitalized or who died after discharge. What is added by this report? Updated guidance recommends posthospitalization outpatient follow-up, optimally within 48 hours of discharge, and emphasizes the importance of preparation for hospital discharge and postdischarge care coordination to reduce risk of rehospitalization and death among hospitalized EVALI patients. What are the implications for public health practice? Incorporating this updated guidance into the management of hospitalized EVALI patients might reduce EVALI-associated morbidity and mortality. [Description provided by NIOSH]
• Subjects:
  Cannabis Communicable Diseases Electrical Equipment And Supplies Hazardous Substances Health Care Facilities Workforce And Services Health Personnel Health Promotion Influenza, Human Lung Lung Diseases Morbidity Mortality Occupational Health Public Health Respiratory System Respiratory Tract Diseases Safety Smokers Solvents Tobacco Products Vaping

  More +
• Keywords:
  Humans; Cigarette smoking; Vapors; Toxic materials; Lung; Lung disorders; Lung disease; Medical management guidelines; Medical monitoring; Guidelines; Recommendations; Public health; Health protection; Mortality data; Surveillance; Health care; Health communications; Morbidity rates; Health care personnel; Medical personnel; Pulmonary disorders; Pulmonary effects; Pulmonary system disorders; Cannabis; Tobacco; Electronic devices; Influenza; Antimicrobials; Antiviral; Corticosteroids
• Source:
  MMWR 2020 Jan; 68(51-52):1189-1194
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195
• Pubmed ID:
  31895915
• Pubmed Central ID:
  PMC6943965
• Document Type:
  Text
• Genre:
  Journal Article
• Place as Subject:
  California ; Georgia ; Minnesota ; Ohio ; OSHA Region 10 ; OSHA Region 3 ; OSHA Region 4 ; OSHA Region 5 ; OSHA Region 6 ; OSHA Region 8 ; OSHA Region 9 ; Texas ; Utah ; Washington ; West Virginia
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  RHD - Respiratory Health Division
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  6 pdf pages
• Volume:
  68
• Issue:
  51
• NIOSHTIC Number:
  nn:20058184
• Contact Point Address:
  Mary E. Evans, MD, National Center for Injury Prevention and Control, CDC, Atlanta, GA
• Email:
  eocevent32@cdc.gov
• CAS Registry Number:
  Cannabis (CAS RN 8063-14-7) ; Tobacco oil (CAS RN 8037-19-2)
• Federal Fiscal Year:
  2020
• Peer Reviewed:
  False
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR) National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:74055c96a6791e76aa2ebc040cb2253f1ed61d6fafcb89deaf43f51be4e07e3de26d46d1fcadef711d0f79394d19a8d1eb48879cc516b11853bdb8fc057a8ae3
• Download URL:
  https://stacks.cdc.gov/view/cdc/84446/cdc_84446_DS1.pdf
• File Type:
  [PDF - 135.18 KB ]